Status:
COMPLETED
Effects of tDCS on People With Fibromyalgia
Lead Sponsor:
University of Extremadura
Collaborating Sponsors:
Ministerio de Asuntos Economicos y Transformación Digital, España
Junta de Extremadura, España
Conditions:
Fibromyalgia
Eligibility:
FEMALE
30-75 years
Brief Summary
People with fibromyalgia could experience physical and cognitive impairment as well as higher dual-task cost than healthy people when two tasks are performed simultaneously. Transcranial direct curren...
Detailed Description
Fibromyalgia is characterized by widespread pain and other associated symptoms, including stiffness, fatigue, non-recovery sleep, anxiety, or depression. On a physical level, people with FM frequently...
Eligibility Criteria
Inclusion
- Be able to communicate with the research staff
- Have read, understood, and signed the informed consent form
Exclusion
- Physiatric or neurological disorders
- Pharmacological treatment for anxiety or depression
- Substance abuse or dependence
- Contraindication for physical effort
- Difficulty in maintaining balance
- Leg injury that interferes with flexion and extension of the knee
- Being pregnant
Key Trial Info
Start Date :
February 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 14 2022
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05266989
Start Date
February 7 2022
End Date
March 14 2022
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facultad de Ciencias del Deporte
Cáceres, Spain, 10003